A phase Ill trial to evaluate the efficacy of uproleselan (GMI-1271) with chemotherapy in patients with relapsed/refractory acute myeloid leukemia.-MedSci.cn

A phase Ill trial to evaluate the efficacy of uproleselan (GMI-1271) with chemotherapy in patients with relapsed/refractory acute myeloid leukemia.

DeAngelo, DJ; Erba, HP; Jonas, BA; O'Dwyer, M; Marlton, P; Huls, GA; Liesveld, J; Cooper, BW; Bhatnagar, B; Armstrong, M; Fogler, W; Chen, M; Magnani, J; Thackray, HM; Advani, AS; Becker, PS

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

科室
- - 订阅+
  - 更多科室
工具
服务